Clinical Research Directory

Long-term Follow-up Study of AL-001 Ophthalmic Injection in Subjects with WAMD

Sponsor: Beijing Anlong Biopharmaceutical Co., Ltd.

Summary

This study is designed to evaluate long-term safety and efficacy of AL-001 ophthalmic injection following suprachoroidal space(SCS) administration in subjects with wAMD. Eligible patients, are those who were previously enrolled in a clinical study in which they received a single dose of AL-001 administered via suprachoroidal space injection.

Official title: A Long-term Follow-up Study to Evaluate the Safety and Effectivity of AL-001 Ophthalmic Injection in Subjects with Wet Age-related Mecular Degeneration (wAMD)

Key Details

Conditions

Locations (1)